Cannasouth Ltd
NZX:CBD
Cannasouth Ltd
NZX:CBD
Price:
0.098
NZD
Market Closed
Market Cap:
NZ$32.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Arabian Drilling Co
SAU:2381
|
SA |
|
Best Buy Co Inc
NYSE:BBY
|
US |
Cannasouth Ltd
Note Receivable
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Cannasouth Ltd
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cannasouth Ltd
NZX:CBD
|
Note Receivable
NZ$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
BLIS Technologies Ltd
NZX:BLT
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Rua Bioscience Ltd
NZX:RUA
|
Note Receivable
NZ$75k
|
CAGR 3-Years
0%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Cannasouth Ltd
Glance View
Cannasouth Ltd. is a biopharmaceutical, research and development company, which develops medicinal cannabis products. The firm focuses on the commercial development of the medically beneficial attributes of cannabinoid compounds such as Cannabidiol (CBD), Tetrahydrocannabinol (THC) and associated chemical structures that are produced by the cannabis plant.
CBD
Intrinsic Value
Not Available
See Also
What is Cannasouth Ltd's Note Receivable?
Note Receivable
0
NZD
0
NZD
Based on the financial report for Dec 31, 2023, Cannasouth Ltd's Note Receivable amounts to 0 NZD.
